Search results for "Education"
Physician-patient discussions may decrease unnecessary self-monitoring of blood glucose levels
In a cross-sectional survey at an Ohio health system, 67% of respondents with non-insulin-controlled type 2 diabetes said they monitored their blood glucose levels because their physician had asked them to, and 50% said they would stop if given permission.
https://diabetes.acponline.org/archives/2021/09/10/2.htm
10 Sep 2021
Spotlight on diabetes and sleep disorders
One review looked at rates of sleep disorders in patients with diabetes, another study found that the combination of impaired glucose tolerance and a sleep disorder increases mortality risk, and patient interviews revealed benefits and barriers to use of continuous positive airway pressure.
https://diabetes.acponline.org/archives/2021/09/10/5.htm
10 Sep 2021
Consensus report aims to define remission of diabetes
An international expert group convened by the American Diabetes Association proposed that the criterion for diabetes remission be an HbA1c level below 6.5%, measured at least three months after glucose-lowering drugs are stopped.
https://diabetes.acponline.org/archives/2021/09/10/1.htm
10 Sep 2021
Spotlight on diabetes prevalence and control
Diabetes became significantly more common from 1999 to 2018, but control of associated risk factors did not, especially in rural areas of the U.S., according to data from the National Health and Nutrition Examination Survey.
https://diabetes.acponline.org/archives/2021/07/09/5.htm
9 Jul 2021
Nearly 50% of older U.S. adults reported taking aspirin preventively
A study of National Health and Nutrition Examination Survey data from 2011 to 2018 found that 46.7% of respondents ages 60 years and older used aspirin for primary or secondary cardiovascular disease prevention and suggested potential overuse in certain groups.
https://diabetes.acponline.org/archives/2021/07/09/7.htm
9 Jul 2021
SGLT2 inhibitors reduce all-cause mortality
A recent meta-analysis found lowered mortality risk with sodium-glucose cotransporter-2 (SGLT2) inhibitors, and an ACP Journal Club commentary added that other trials have shown beneficial effects of the drug class on kidney function in patients with type 2 diabetes.
https://diabetes.acponline.org/archives/2021/05/14/6.htm
14 May 2021
AHA issues policy statement on reducing lower-extremity amputations
Amputations among U.S. patients with diabetes decreased between 2000 and 2009 but increased by 50% from 2009 to 2015, leading the American Heart Association (AHA) to call for better identification and treatment of peripheral artery disease and propose policy solutions.
https://diabetes.acponline.org/archives/2021/04/09/3.htm
9 Apr 2021
Incidence of diagnosed diabetes may be stable or declining in many countries
An analysis of 21 mostly high-income countries or jurisdictions found a downward or stable trend in clinically diagnosed diabetes incidence in recent years, but the drivers of these trends remain unknown, an accompanying editorial comment said.
https://diabetes.acponline.org/archives/2021/03/12/1.htm
12 Mar 2021
Some glucose-lowering drugs reduce HbA1c more than others
A recent meta-analysis supports the use of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in patients with diabetes and elevated cardiovascular risk, but cost remains a barrier, an ACP Journal Club commentary said.
https://diabetes.acponline.org/archives/2020/12/11/8.htm
11 Dec 2020
Group-based lifestyle intervention reduced risk of type 2 diabetes
Participants in the Norfolk Diabetes Prevention Study who underwent multiple educational group sessions that included 50-minute sessions of supervised physical activity had significantly lower odds of type 2 diabetes during a mean follow-up of two years compared to those who received usual care.
https://diabetes.acponline.org/archives/2020/11/13/9.htm
13 Nov 2020